about
Mutual information as a measure of image quality for 3D dynamic lung imaging with EITMultiparametric cardiovascular magnetic resonance surveillance of acute cardiac allograft rejection and characterisation of transplantation-associated myocardial injury: a pilot study.Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.Voxel-wise quantification of myocardial blood flow with cardiovascular magnetic resonance: effect of variations in methodology and validation with positron emission tomography.Preimplant transthoracic echocardiographic assessment of continuous flow left ventricular assist device.Non-invasive approaches for the diagnosis of acute cardiac allograft rejection.Republished: Cardiac MRI of patients with implanted electrical cardiac devices.Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.The Value of Cardiovascular Magnetic Resonance in Heart Transplant Patients.Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases.Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI.Quantification of left ventricular indices from SSFP cine imaging: impact of real-world variability in analysis methodology and utility of geometric modeling.Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy.Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy.Incidental extra-cardiac findings on clinical CMR.The effect of 1.5 T cardiac magnetic resonance on human circulating leucocytes.Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.Cardiovascular magnetic resonance validation of fractional changes in annulo-apical angles and tricuspid annular plane systolic excursion for rapid assessment of right ventricular systolic function.Unrecognized Myocardial Infarction: Time to Rectify Failures of Detection and Failures of Prevention.Myocardial tissue characteristics undoubtedly differ by gender but not age.Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction".Comparison of local sine wave modeling with harmonic phase analysis for the assessment of myocardial strain.Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathyOutcome Measures in HFpEF TrialsDiagnosing Cardiac Allograft VasculopathyAn unusual case of cardiomyopathyDiagnosis of acute myocarditis by cardiovascular magnetic resonance in a patient with chest pain, positive troponin, and normal coronary arteriesEpicardial lipomatous hypertrophy mimicking pericardial effusion: characterization with cardiovascular magnetic resonanceLocalised myocardial scar related to left ventricular false tendonsMultiparametric cardiovascular magnetic resonance assessment of pacemaker-induced alterations in ventricular activation and functionComprehensive characterization of constrictive pericarditis using multiparametric CMRCardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials
P50
Q30580783-77304968-4E7E-4C4E-8BEC-B7C0DD0B1614Q34001030-92325D5E-DE2A-42D5-95B8-B1588854D886Q36935205-A4928D4F-46C8-4C3C-81D7-D5EB8D431ED5Q37524613-186995E1-88E1-4F75-907A-05CAF1DFA91EQ37969196-543BAF9E-2BC6-42FC-AA98-450A8E2C14BCQ38068995-A7DBEAB3-39C7-4351-A563-4A85EFC45ED5Q38272265-AF61F9E9-73BD-48A5-9A3D-24733CB5379AQ38451700-664144D3-F49F-44C1-81AF-AB27636123A8Q38521542-9FEB1356-9B0A-48C3-B6AA-965A0758AEC6Q39107209-241B6300-EE56-45F7-83FF-9F56D253A309Q42392198-E20000F6-FC79-49BF-A4AC-A6758323296CQ45333622-C670C8EE-D2EF-4C6F-AAC4-73DAF7A07917Q46590571-E825DCC2-281B-4A8E-BF44-D492271C9418Q46748852-706E5691-EA4F-4BEC-A67C-4AFED888BEDFQ47409571-7D26FD27-D93C-44B4-8828-AE0C1450ACF7Q47703046-BEF52F93-5926-4C63-A047-39166557A84FQ50098362-BE447302-9B83-4E54-A1E9-7FFF0D4FF918Q51079719-C1907756-03C2-401C-9D76-874303127EBBQ52717758-9442CF01-46C8-4930-8823-6ED94B4FF1F3Q52719846-0B6D460D-0C75-4E87-87D3-05C1B87FB2C6Q52725625-237AED11-FA1A-475E-85CB-25A42E8C342BQ52782392-D7603839-6527-4D83-B0ED-139EA44ED089Q53128583-4F66E50B-D615-4DCA-9E62-C9AB609802C8Q58095367-CFD88E13-C522-4273-B150-389BC2AE2FDBQ59683533-0E662545-9586-4C08-B42A-B6C578145642Q61650950-88F05FE8-A7E1-451B-88F7-7DD809163043Q79307624-3727D426-38FE-4F15-AF31-E74CA93C5A99Q82711036-A25F5FD3-EF62-4A83-B484-B9664CD9F46DQ83231243-3BAEB192-5E0A-4034-996A-0139E02B68D7Q83772074-09992724-639B-4F3D-BEA4-8A366916F909Q84690778-54FE7B1A-4483-4C03-BE66-EE1FFF19CB07Q84748274-633BDDF9-E3DF-4B4A-91FA-B5A26F0A2F7CQ88678091-98EBFFF8-0484-4B08-B1B7-16C12240E75A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5957-7088
@en
name
Christopher A Miller
@ast
Christopher A Miller
@en
Christopher A Miller
@es
Christopher A Miller
@nl
type
label
Christopher A Miller
@ast
Christopher A Miller
@en
Christopher A Miller
@es
Christopher A Miller
@nl
prefLabel
Christopher A Miller
@ast
Christopher A Miller
@en
Christopher A Miller
@es
Christopher A Miller
@nl
P106
P1153
57203424537
P21
P31
P496
0000-0002-5957-7088